Press Releases

Stevia Corp. Announces All July 15 Trades Sequestered Due to Error by FINRA

PDF Print E-mail

INDIANAPOLIS, IN--(Marketwired - Jul 16, 2013) - Stevia Corp. (OTCQB: STEV) ("Stevia Corp" or the "Company"), a farm management company focused on the economic development of stevia, the fastest growing product in the alternative sweetener sector, wishes to inform the public that the Financial Industry Regulatory Authority (FINRA) acknowledged that due to an error on its part, the trading symbol for Stevia Corp. (STEV) was erroneously displayed as invalid on Monday, July 15th and will be corrected as of market open on July 16, 2013.

As a result, FINRA sequestered all trades made on July 15th, apologized to the Company and the Company in turn extends an apology for the concern this caused to its shareholders. In related news, the company wishes to advise it has filed its annual 10-K financial report with the SEC at http://www.sec.gov.

George Blankenbaker, Stevia Corp President, comments, "This was a very unfortunate situation that was beyond our control, so we wanted to take this opportunity to assure all of our shareholders that Stevia has remained on track with our development plans as laid out in our Form 8-K filed on June 29th, 2011 and that we actually commenced commercialization ahead of schedule generating over $2 million of revenue during the quarter ending March 31st, 2013 and we are now firmly focused on the continued expansion of our proven business model."

Further details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information visit: www.steviacorp.us.

About Stevia Corp. (OTCQB: STEV)
Stevia Corp. is a farm management company focused on best practice agronomic competency in order to deliver high-value stevia through proprietary plant breeding, excellent agricultural methodologies and innovative post-harvest techniques. To date, the Company has acquired two grower supply contracts and three nursery fields in Vietnam. For more information visit: www.steviacorp.us.

About the Stevia Industry Sector
Within two years of the USA market opening, Nielsen-based retail consumption data indicated almost $1 billion of retail sales for the sector. In 2010, stevia products were launched across thirty-five countries and in 38 categories. Zenith International estimates worldwide sales of stevia extract reached 3,500 tons in 2010 with an overall market value of $285 million and forecasts the global market for stevia will reach 11,000 tons by 2014 requiring the tripling of stevia leaf production at the farm level to keep pace with consumer demand. For more information visit: www.steviacorp.us.

Penny Stock Monster

 

HALO, Halozyme, BAX, Baxter, announce positive results, 03/22/2013

PDF Print E-mail

HALO, Halozyme, BAX, Baxter, announce positive results, 03/22/2013

Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union

 

LONDON, March 22, 2013 /PRNewswire/ -- Baxter International Inc. (BAX) and Halozyme Therapeutics, Inc., (HALO) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (EMA CHMP) has granted a Positive Opinion to Baxter for the use of HyQvia (solution for subcutaneous use) as replacement therapy for adult patients with primary and secondary immunodeficiencies. The product is a combination of human normal immunoglobulin (IGSC, 10%) and recombinant human hyaluronidase, which facilitates the dispersion and absorption of the IGSC.

"This recommendation supports our efforts to improve the overall quality of care for patients. This therapy, when approved by the European Commission, would offer patients the option to administer their therapy at home, in a single subcutaneous site every three to four weeks, resulting in potentially lower systemic adverse reactions compared to intravenous treatments," said Ludwig Hantson, Ph.D., president of Baxter's BioScience business. "We look forward to introducing HyQvia as a new patient-friendly therapeutic option for immunodeficient patients."

The application was based on results from a phase III, prospective, open-label, non-controlled design clinical trial, which evaluated the safety and effectiveness of HyQvia in the prevention of acute serious bacterial infections, and the pharmacokinetic parameters compared to immunoglobulin administered intravenously. The objective of the study was to infuse a 3-or 4-week dose of the therapy in a single subcutaneous site. The acute serious bacterial infection rate in the study was 0.025 per patient per year, which is below the required efficacy threshold of 1.0 (serious bacterial infections per patient per year). In the tolerability assessment of HyQvia, the most frequently reported adverse reactions were infusion site reactions (20% of infusions), headache (3% of infusions), fatigue (1% of infusions) and pyrexia (fever) (1% of infusions). Upon receiving marketing authorization from the European Commission, Baxter plans to launch HyQvia in selected countries in the European Union later this year.

"Recognizing that the path to approval for any biologic is a long journey, I would like to thank and congratulate the teams at Halozyme and Baxter who have worked tirelessly to advance this therapeutic option for patients," said Gregory I. Frost, Ph.D., president and chief executive officer, Halozyme Therapeutics.

Sources: Baxter, Halozyme, OxBridge Research, Daily Stock Deals

 

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

Get the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up, its FREE!

 

Baristas,BCCI,BAPI, receives a new Symbol from NASDAQ Capital Markets

PDF Print E-mail

Baristas Receives NASDAQ Capital Market Symbol "BAPI"

SEATTLE, March 6, 2013 /PRNewswire/ -- Baristas Coffee Company, Inc. (BCCI), a fast growing U.S. based beverage and branded products company, has today announced that it has completed all requirements and that its application to receive a symbol to be traded on the NASDAQ Capital Market has been approved. The symbol issued to Baristas Coffee Company is (NASDAQ:BAPI). 

Baristas will continue to trade under the symbol OTCPK:BCCI  throughout the application process and comment periods until such time as it completes its up listing and begins to trade on the NASDAQ Capital Markets at which time it will trade under the newly reserved symbol NASDAQ:BAPI.

The companies that are listed on NASDAQ Capital Market need to satisfy all the required qualifications for NASDAQ securities in Rule 4300. The companies also need to adhere to the corporate governance standards set by NASDAQ.

The NASDAQ Capital Market provides companies the required capital in order to grow their business. The NASDAQ Capital Market also provides a listing venue that promises to accommodate the different stages of corporate lives of the companies.

Barry Henthorn CEO commented; "This is an important step in the process of BCCI moving from the OTC to the NASDAQ Capital Market.  We have worked diligently in conjunction with our advisors in order to be in a position to take this step and will continue to do so throughout the application, comments and approval process. We are committed to providing our investors transparency and oversight as we continue to develop and expand our business.  We are confident that we will be able to meet all of the listing requirements to begin trading in a reasonable timeframe."

About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Texas, Florida, Arizona, and Montana. Your state, Coming Soon!

For more information on this fascinating concept please visit us at www.baristas.tv

Source: the company, OxBridge Research

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Baristas,BCCI,BAPI,bare skin hot coffee,competing with starbucks,sbux,seatles best,green mountain,gmcr


 

 

STEV, Stevia, licensing revenues to accelerate earnings. Stevia pre-sold entire crop

PDF Print E-mail

Stevia Corp. Poised to Harvest First Crop in Vietnam

Current Harvest Pre-Sold as New Products Begin Sales Under License Contributing to Additional Earnings

 

INDIANAPOLIS, IN--(Marketwire - Mar 5, 2013) - Stevia Corp. ( OTCQB : STEV ) ("Stevia Corp" or the "Company"), a farm management company focused on the economic development of stevia, the fastest growing product in the alternative sweetener sector, is pleased to announce that the first major crop harvest in Vietnam is on track and on schedule.

As previously announced, Stevia Corp anticipates its current crop harvest in Vietnam to generate in excess of USD$2 million in revenues from more than 1,000 tons of harvest. Current field reports indicate that the projected harvest expectations will easily be met.

George Blankenbaker, Stevia Corp President, comments, "Based on early test field results and current field crop conditions, we anticipate a strong harvest during March, April and May."

Expansion of the current model is planned in August and the Company intends to increase production by a factor of 5 times by next spring subject to adequate capital.

Mr. Blankenbaker adds, "We have already established the infrastructure to support our projected growth and we have farmers on a waiting list to participate in our program. Our major advantage is that proficient farmers are able to more than double their income by participating in our program. This creates a ripple effect of support and enthusiasm from all parties involved, making it much easier to manage high growth expansion."

Additional revenue is expected to be generated from the sale of the Company's proprietary products formulated with stevia extracts, probiotics and enzymes. More than 100 farm operators have tested the products with excellent results and the Company is now making the products commercially available for sale under license.

Mr. Blankenbaker concludes, "Our farm management model will generate the quickest path to profitability and near-term growth, but long-term there is significant opportunity to leverage our technology and increase revenue and margins and build brand value from our growing portfolio of proprietary products."

Further details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information visit: www.steviacorp.us.

About Stevia Corp. ( OTCQB : STEV )
Stevia Corp. is a farm management company focused on best practice agronomic competency in order to deliver high-value stevia through proprietary plant breeding, excellent agricultural methodologies and innovative post-harvest techniques. To date, the Company has acquired two grower supply contracts and three nursery fields in Vietnam. For more information visit: www.steviacorp.us.

About the Stevia Industry Sector
Within two years of the USA market opening, Nielsen-based retail consumption data indicated almost $1 billion of retail sales for the sector. In 2010, stevia products were launched across thirty-five countries and in 38 categories. Zenith International estimates worldwide sales of stevia extract reached 3,500 tons in 2010 with an overall market value of $285 million and forecasts the global market for stevia will reach 11,000 tons by 2014 requiring the tripling of stevia leaf production at the farm level to keep pace with consumer demand. For more information visit: www.steviacorp.us.

Source: the company, OxBridge Research 

 
Page 2 of 6
Penny Stock Monster
Sound View Plaza, 7th Floor
1266 E Main St.
Stamford, CT 06902, US
FREE! Premium Membership. DON'T miss the next Exclusive Alert! Become
a MEMBER Today!

Look for exclusive alerts

The Score Card

ARTI.PK* 0.0021   + 52%
EHSK.PK 0.17   + 108%
HGSI 3.35   + 226%
INCC.OB 0.01   + 346%
JGPK.OB 0.18   + 116%
STZU.PK 0.12   + 41%
TTEG.OB 0.36   + 156%

 

Look us up ON
these and other
PREMIER FINANCIALweb sites.
FREE! Premium Membership. DON'T miss the next Exclusive Alert! Become a MEMBER Today!